Abstract
An unexpectedly high incidence of thrombosis in patients that received the polylactic acid bioresorbable vascular scaffold (BVS) suggests a delayed/incomplete endothelial repair with this stent. The anti-platelet agent tirofiban stimulates endothelial cell migration and proliferation, mediated by VEGF production. We investigated the tirofiban effect on the migration and adhesion of endothelial cells to BVS, in vitro. We performed human umbilical endothelial cell (HUVEC) cultures in the presence of BVS. Tirofiban, similarly to VEGF, increased the ability of HUVEC to grow on the vascular scaffold, compared to unstimulated or abciximab-treated cells. Tirofiban increased HUVEC expression of β1 and β3 integrins along with collagen and fibronectin. A role for β1 integrin in the “pro-adhesive and -migratory” signals elicited by tirofiban was suggested by use of an anti-β1-blocking antibody that prevented poly-levo-lactic acid vascular scaffold colonization. Our study suggests that tirofiban may improve the outcomes of patients receiving BVS by accelerating stent endothelization.
Similar content being viewed by others
References
Tenekecioglu, E., Farooq, V., Bourantas, C. V., et al. (2016). Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention. BMC Cardiovascular Disorders, 16, 38. https://doi.org/10.1186/s12872-016-0207-5.
Gogas, B. D. (2014). Bioresorbable scaffolds for percutaneous coronary interventions. Global Cardiology Science and Practice, 4, 409–427. Review. https://doi.org/10.5339/gcsp.2014.55.
Brugaletta, S., Heo, J. H., Garcia-Garcia, H. M., et al. (2012). Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: Indirect finding of vascular reparative therapy. European Heart Journal, 33, 1325–1333. https://doi.org/10.1093/eurheartj/ehr466.
Räber, L., Brugaletta, S., Yamaji, K., et al. (2015). Very late scaffold thrombosis intracoronary imaging and histopathological and spectroscopic findings. Journal of the American College of Cardiology, 66, 1901–1914. https://doi.org/10.1016/j.jacc.2015.08.853.
Hiltrop, N., Jorge, C., Bennett, J., et al. (2016). Late neoatherosclerotic scaffold failure: an unexpected Achilles heel for current bioresorbable scaffold technology? International Journal of Cardiology, 223, 133–135. https://doi.org/10.1016/j.ijcard.2016.08.076.
Lau, A. K., Leichtweis, S. B., Hume, P., et al. (2003). Probucol promotes functional reendothelialization in balloon-injured rabbit aortas. Circulation, 107, 2031–2036. https://doi.org/10.1161/01.CIR.0000062682.40051.43.
Wu, X., Zhao, Y., Tang, C., et al. (2016). Re-Endothelialization study on endovascular stents seeded by endothelial cells through up- or downregulation of VEGF. ACS Applied Materials & Interfaces, 8, 7578–7589. https://doi.org/10.1021/acsami.6b00152.
Windecker, S., Kolh, P., Alfonso, F., et al. (2014). European Heart Journal, 35, 2541–2619. ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). https://doi.org/10.1093/eurheartj/ehu278.
Heestermans, A. A., Van Werkum, J. W., Hamm, C., et al. (2009). Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction. Journal of Thrombosis and Haemostasis, 7, 1612–1618. https://doi.org/10.1111/j.1538-7836.2009.03573.x.
Giordano, A., D'Angelillo, A., Romano, S., et al. (2014). Tirofiban induces VEGF production and stimulates migration and proliferation of endothelial cells. Vascular Pharmacology, 61, 63–71. https://doi.org/10.1016/j.vph.2014.04.002.
Fonsatti, E., Sigalotti, L., Arslan, P., et al. (2003). Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies. Current Cancer Drug Targets, 3, 427–432. https://doi.org/10.2174/1568009033481741.
Reinhart-King, C. A. (2008). Endothelial cell adhesion and migration. Methods in Enzymology, 443, 45–64. https://doi.org/10.1016/S0076-6879(08)02003-X.
Massé, J. M., Perlemuter, K., Debili, N., et al. (1999). Intracellular trafficking of the alphaIIbbeta3 receptor antagonist, abciximab, in normal and Glanzmann’s disease megakaryocytes. British Journal of Haematology, 107, 720–730. https://doi.org/10.1046/j.1365-2141.1999.01768.x.
Fässler, R., Pfaff, M., Murphy, J., et al. (1995). Lack of beta 1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts. The Journal of Cell Biology, 128, 979–988. https://doi.org/10.1083/jcb.128.5.979.
Giampietro, C., Taddei, A., Corada, M., et al. (2012). Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells. Blood, 119, 2159–2170. https://doi.org/10.1182/blood-2011-09-381012.
Gao, H., Zhang, J., Liu, T., et al. (2011). Rapamycin prevents endothelial cell migration by inhibiting the endothelial-to-mesenchymal transition and matrix metalloproteinase-2 and -9: an in vitro study. Molecular Vision, 17, 3406–3414.
Xia, Y., Boey, F., & Venkatraman, S. S. (2010). Surface modification of poly (L-lactic acid) with biomolecules to promote endothelialization. Biointerphases, 5, FA32–FA40. https://doi.org/10.1116/1.3467508.
Bautch, V. L. (2017). Endoglin moves and shapes endothelial cells. Nature Cell Biology, 19, 593–595. https://doi.org/10.1038/ncb3543.
Rossi, E., Smadja, D. M., Boscolo, E., et al. (2016). Endoglin regulates mural cell adhesion in the circulatory system. Cellular and Molecular Life Sciences, 73, 1715–1739. https://doi.org/10.1007/s00018-015-2099-4.
Huttenlocher, A., & Horwitz, A. R. (2011). Integrins in cell migration. Cold Spring Harbor Perspectives in Biology, 3, a005074. https://doi.org/10.1101/cshperspect.a005074.
Lamouille, S., Xu, J., & Derynck, R. (2014). Molecular mechanisms of epithelial-mesenchymal transition. Nature Reviews. Molecular Cell Biology, 15, 178–196. https://doi.org/10.1038/nrm3758.
Jin, Y., Muhl, L., Burmakin, M., Wang, Y., Duchez, A. C., Betsholtz, C., Arthur, H. M., & Jakobsson, L. (2017). Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling. Nature Cell Biology, 19, 639–652. https://doi.org/10.1038/ncb3534.
Cox, E. A., Sastry, S. K., & Huttenlocher, A. (2001). Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the rho family of GTPases. Molecular Biology of the Cell, 12, 265–277. https://doi.org/10.1091/mbc.12.2.265.
Butler, J. M., Kobayashi, H., & Rafii, S. (2010). Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nature Reviews. Cancer, 10, 138–146. https://doi.org/10.1038/nrc2791.
Raynaud, C. M., Butler, J. M., Halabi, N. M., Ahmad, F. S., Ahmed, B., Rafii, S., & Rafii, A. (2013). Endothelial cells provide a niche for placental hematopoietic stem/progenitor cell expansion through broad transcriptomic modification. Stem Cell Research, 11, 1074–1090. https://doi.org/10.1016/j.scr.2013.07.010.
Funding
We thank Cardiovascular Service for supporting our research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Arturo Giordano is a consultant for Medtronic and Abbot; Simona Romano declares that she has no conflict of interest; Nicola Corcione declares that he has no conflict of interest; Giacomo Frati declares that he has no conflict of interest; Giuseppe Biondi Zoccai has consulted for Bayer and Abbot Vascular; Paolo Ferraro and Stefano Messina declares that they have no conflict of interest; Stefano Ottolini is a consultant for Correvio Italia, Cardiome Sarl; Maria Fiammetta Romano declares that she has no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Associate Editor Adrian Chester oversaw the review of this article
Electronic supplementary material
ESM 1
(PDF 162 kb)
Rights and permissions
About this article
Cite this article
Giordano, A., Romano, S., Corcione, N. et al. Tirofiban Positively Regulates β1 Integrin and Favours Endothelial Cell Growth on Polylactic Acid Biopolymer Vascular Scaffold (BVS). J. of Cardiovasc. Trans. Res. 11, 201–209 (2018). https://doi.org/10.1007/s12265-018-9805-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-018-9805-1